Two hemophilia patients in the U.S. who struggled for years with bleeds have been given Hemgenix, the first gene therapy ...

Columnist G Shellye Horowitz wasn't surprised to learn she had osteopenia, as her bleeding disorder increases her risk of low ...

Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended ...

Columnist Jennifer Lynne reflects on her most-read columns from last year and why those stories resonated with the hemophilia community.

MacDonald worries about her adult son being complacent when it comes to administering his hemophilia medication.

Columnist Joe MacDonald's son struggled to balance school and hemophilia during his first semester of college. Now, he's better prepared.

Columnist Alliah Czarielle says a conversation she had with her husband about manual wheelchairs surprised her.

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s concizumab, which will be sold under the brand name Alhemo, as a daily treatment to prevent or reduce the frequency of bleeding ...

In 2024, Hemophilia News Today provided readers with up-to-date coverage on research, treatments, and clinical trials for hemophilia. We compiled the top 10 most-read stories of the year, each with a ...

While she's still learning to navigate life with ADHD, columnist Alliah Czarielle has found that the condition benefits her as a caregiver.